Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- PANTHERIndependent statistical analysis of Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD): primary endpoint results, effect estimate…
- Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835588).
- PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00088413).
- PAPALIndependent statistical analysis of A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01667107).
- PAPIIndependent statistical analysis of Potency and Precision Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06240091).
- PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): Complete Statistical AnalysisIndependent statistical analysis of PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Paracervical Block for Pain Associated With Laminaria Insertion: Complete Statistical AnalysisIndependent statistical analysis of Paracervical Block for Pain Associated With Laminaria Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02454296).
- Paracetamol With Caffeine to Treat Episodic Tension Type Headache: Complete Statistical AnalysisIndependent statistical analysis of Paracetamol With Caffeine to Treat Episodic Tension Type Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755702).
- Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Parental Perceptions on Prescription Opioid Use: Complete Statistical AnalysisIndependent statistical analysis of Parental Perceptions on Prescription Opioid Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05344118).
- ParicalcitolIndependent statistical analysis of The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PARQuitIndependent statistical analysis of PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03950427).
- Parrying the Pitfalls of PrEP: Project PEACH: Complete Statistical AnalysisIndependent statistical analysis of Parrying the Pitfalls of PrEP: Project PEACH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05072093).
- PARTIndependent statistical analysis of PsA Treatment With hOKT3γ1 (Ala-Ala): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00239720).
- PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations: Complete Statistical AnalysisIndependent statistical analysis of PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations: Complete Statistical AnalysisIndependent statistical analysis of PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris: primary endpoint results, effect estimate with confidence interval,…
- Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers: Complete Statistical AnalysisIndependent statistical analysis of Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PASIndependent statistical analysis of Post Approval Study of the Eversense® Continuous Glucose Monitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03908125).
- PASCALRegistryIndependent statistical analysis of Edwards PASCAL Transcatheter Valve Repair System Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04443218).
- Pasos Hacia La Salud – Physical Activity Intervention for Latinas: Complete Statistical AnalysisIndependent statistical analysis of Pasos Hacia La Salud - Physical Activity Intervention for Latinas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01834287).
- PASS DEGENIndependent statistical analysis of The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems (PASS DEGEN): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PATCHIndependent statistical analysis of Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PATCHIndependent statistical analysis of Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02855060).
- PATHIndependent statistical analysis of PATH Partnering to Achieve Tobacco-free Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01533974).
- PATHIndependent statistical analysis of Perindopril Amlodipine for the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01556997).
- PATH-MCIIndependent statistical analysis of Problem Adaptation Therapy for Mild Cognitive Impairment and Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03043573).
- PATHFINDERIIIndependent statistical analysis of Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett’s Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Patient Centered Postpartum Contraception App: Complete Statistical AnalysisIndependent statistical analysis of Patient Centered Postpartum Contraception App: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03402217).
- Patient Convenience Study (RE-SONANCE): Complete Statistical AnalysisIndependent statistical analysis of Patient Convenience Study (RE-SONANCE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02684981).
- Patient Preference Comparison of AZARGA Versus COSOPT: Complete Statistical AnalysisIndependent statistical analysis of Patient Preference Comparison of AZARGA Versus COSOPT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340014).
- Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software: Complete Statistical AnalysisIndependent statistical analysis of Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching: Complete Statistical AnalysisIndependent statistical analysis of Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678444).
- Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Patients With Geographic Atrophy and Their Patient Journey in the United States (US): Complete Statistical AnalysisIndependent statistical analysis of Patients With Geographic Atrophy and Their Patient Journey in the United States (US): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PATTErnIndependent statistical analysis of A Study of Physical Activity paTTerns and Major Health Events in Older People With Implantable Cardiac Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00625846).
- Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC): Complete Statistical AnalysisIndependent statistical analysis of Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01392183).
- PBFR2Independent statistical analysis of Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PBroCIndependent statistical analysis of Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265953).
- PCMH-KDIndependent statistical analysis of Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02270515).
- PCN1Independent statistical analysis of Patient Centered-Rehabilitation ver111090.1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03034954).
- PCORI Urea Cycle Disorder Study: Complete Statistical AnalysisIndependent statistical analysis of PCORI Urea Cycle Disorder Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02740153).
- PCOSIndependent statistical analysis of Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PCR PS TKAIndependent statistical analysis of Knee Kinematics for Subjects With Zimmer-Biomet Posterior Cruciate Retaining or Posterior Stabilizing Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung: Complete Statistical AnalysisIndependent statistical analysis of PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…